Stefanie Hennig

1.6k total citations
82 papers, 1.2k citations indexed

About

Stefanie Hennig is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Infectious Diseases. According to data from OpenAlex, Stefanie Hennig has authored 82 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pharmacology, 19 papers in Pediatrics, Perinatology and Child Health and 17 papers in Infectious Diseases. Recurrent topics in Stefanie Hennig's work include Antibiotics Pharmacokinetics and Efficacy (25 papers), Cystic Fibrosis Research Advances (13 papers) and Pneumonia and Respiratory Infections (13 papers). Stefanie Hennig is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (25 papers), Cystic Fibrosis Research Advances (13 papers) and Pneumonia and Respiratory Infections (13 papers). Stefanie Hennig collaborates with scholars based in Australia, United States and Sweden. Stefanie Hennig's co-authors include Christine E. Staatz, Claire Wainwright, Sabariah Noor Harun, Ross Norris, Kerenaftali Klein, Rachael Lawson, Troels K. Bergmann, Mats O. Karlsson, Bruce Charles and Carl M. J. Kirkpatrick and has published in prestigious journals such as PLoS ONE, Antimicrobial Agents and Chemotherapy and Thorax.

In The Last Decade

Stefanie Hennig

81 papers receiving 1.2k citations

Peers

Stefanie Hennig
Nathalie Bleyzac France
Ron J. Keizer Netherlands
Karl Brendel France
Rob ter Heine Netherlands
Catherine Litalien Canada
MO Karlsson Sweden
DR Mould United States
F. Lemaı̂tre France
Eliane M. Billaud France
Sara Baldelli Italy
Nathalie Bleyzac France
Stefanie Hennig
Citations per year, relative to Stefanie Hennig Stefanie Hennig (= 1×) peers Nathalie Bleyzac

Countries citing papers authored by Stefanie Hennig

Since Specialization
Citations

This map shows the geographic impact of Stefanie Hennig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefanie Hennig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefanie Hennig more than expected).

Fields of papers citing papers by Stefanie Hennig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefanie Hennig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefanie Hennig. The network helps show where Stefanie Hennig may publish in the future.

Co-authorship network of co-authors of Stefanie Hennig

This figure shows the co-authorship network connecting the top 25 collaborators of Stefanie Hennig. A scholar is included among the top collaborators of Stefanie Hennig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefanie Hennig. Stefanie Hennig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yamashita, Takeshi, et al.. (2024). Pharmacokinetics of Edoxaban 15 mg in Very Elderly Patients with Nonvalvular Atrial Fibrillation: A Subanalysis of the ELDERCARE-AF Study. Thrombosis and Haemostasis. 124(9). 874–882. 3 indexed citations
2.
Hennig, Stefanie, et al.. (2024). P1.13A.12 Exposure-Response Analyses to Support Ph3 Dose Selection for I-Dxd (Ifinatamab Deruxtecan) in Extensive Stage SCLC Patients. Journal of Thoracic Oncology. 19(10). S212–S212. 1 indexed citations
3.
Michelet, Robin, Jens Markus Borghardt, Teresa Dalla Costa, et al.. (2023). Barriers to global pharmacometrics: educational challenges and opportunities across the globe. CPT Pharmacometrics & Systems Pharmacology. 12(6). 743–747. 7 indexed citations
4.
Holford, Nicholas H. G., Karel Allegaert, Brian J. Anderson, et al.. (2023). A physiological approach to renal clearance: From premature neonates to adults. British Journal of Clinical Pharmacology. 90(4). 1066–1080. 7 indexed citations
5.
Stegemann, Miriam, Frieder Pfäfflin, Agata Mikołajewska, et al.. (2022). Evaluation of a Meropenem and Piperacillin Monitoring Program in Intensive Care Unit Patients Calls for the Regular Assessment of Empirical Targets and Easy-to-Use Dosing Decision Tools. Antibiotics. 11(6). 758–758. 4 indexed citations
6.
Hennig, Stefanie, et al.. (2022). Adaptation of a population pharmacokinetic model to inform tacrolimus therapy in heart transplant recipients. British Journal of Clinical Pharmacology. 89(3). 1162–1175. 7 indexed citations
7.
Hennig, Stefanie, et al.. (2021). Evaluation of published population pharmacokinetic models to inform tacrolimus dosing in adult heart transplant recipients. British Journal of Clinical Pharmacology. 88(4). 1751–1772. 5 indexed citations
8.
Stegemann, Miriam, Frieder Pfäfflin, Wilhelm Huisinga, et al.. (2021). Development of a Model-Informed Dosing Tool to Optimise Initial Antibiotic Dosing—A Translational Example for Intensive Care Units. Pharmaceutics. 13(12). 2128–2128. 2 indexed citations
9.
10.
McIlleron, Helen, David M. Burger, Diana M. Gibb, et al.. (2021). Abacavir pharmacokinetics in African children living with HIV: A pooled analysis describing the effects of age, malnutrition and common concomitant medications. British Journal of Clinical Pharmacology. 88(2). 403–415. 2 indexed citations
11.
12.
Stocker, Sophie L., et al.. (2020). Population Pharmacokinetic Models of Tacrolimus in Adult Transplant Recipients: A Systematic Review. Clinical Pharmacokinetics. 59(11). 1357–1392. 55 indexed citations
13.
Darley, D.R., et al.. (2019). Tacrolimus exposure early after lung transplantation and exploratory associations with acute cellular rejection. European Journal of Clinical Pharmacology. 75(7). 879–888. 5 indexed citations
14.
Hennig, Stefanie, et al.. (2019). Quizzing for success: Evaluation of the impact of feedback quizzes on the experiences and academic performance of undergraduate students in two clinical pharmacokinetics courses. Currents in Pharmacy Teaching and Learning. 11(7). 742–749. 17 indexed citations
15.
Staatz, Christine E., et al.. (2018). How do body composition differences affect gentamicin therapy in pediatric patients. Journal of Pharmacokinetics and Pharmacodynamics. 45. 1 indexed citations
16.
Hennig, Stefanie, et al.. (2018). Monitoring of Tobramycin Exposure: What is the Best Estimation Method and Sampling Time for Clinical Practice?. Clinical Pharmacokinetics. 58(3). 389–399. 19 indexed citations
17.
Hennig, Stefanie, et al.. (2017). Antimicrobial stewardship in paediatric oncology: Impact on optimising gentamicin use in febrile neutropenia. Pediatric Blood & Cancer. 65(2). 18 indexed citations
18.
Nyberg, Joakim, et al.. (2012). PopED: An extended, parallelized, nonlinear mixed effects models optimal design tool. Computer Methods and Programs in Biomedicine. 108(2). 789–805. 67 indexed citations
19.
Lledó‐García, Rocío, Stefanie Hennig, & MO Karlsson. (2009). Comparison of Dose-Finding Designs for Narrow-Therapeutic-Index Drugs: Concentration-Controlled vs. Dose-Controlled Trials. Clinical Pharmacology & Therapeutics. 86(1). 62–69. 5 indexed citations
20.
Hennig, Stefanie, Claire Wainwright, Scott C. Bell, et al.. (2006). Population Pharmacokinetics of Itraconazole and its Active Metabolite Hydroxy-Itraconazole in Paediatric Cystic Fibrosis and Bone Marrow Transplant Patients. Clinical Pharmacokinetics. 45(11). 1099–1114. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nathalie Bleyzac Breakdown of academic impact, for papers by Ron J. Keizer Breakdown of academic impact, for papers by Karl Brendel Breakdown of academic impact, for papers by Rob ter Heine Breakdown of academic impact, for papers by Catherine Litalien Breakdown of academic impact, for papers by MO Karlsson Breakdown of academic impact, for papers by DR Mould Breakdown of academic impact, for papers by F. Lemaı̂tre Breakdown of academic impact, for papers by Eliane M. Billaud Breakdown of academic impact, for papers by Sara Baldelli
Rankless by CCL
2026